Eyenovia reports FY2022 net loss $28.0M; Mydcombi PDUFA date May 8, 2023

HYPERION DEFI, INC.

Net loss $28.0M ($0.83/share) for FY2022 vs $12.8M loss in FY2021; Q4 loss $6.1M.
Cash and equivalents $22.9M at Dec 31, 2022, down from $27.3M at Dec 31, 2021.
FDA accepted Mydcombi NDA; PDUFA action target date May 8, 2023.
Positive Phase 3 results for Microline (presbyopia); FDA feedback outlines clear path forward.
Co-development agreement with Formosa Pharmaceuticals to combine Optejet with APNT nanoparticle platform.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HYPERION DEFI, INC. reported fourth quarter ended December 31, 2022 results: net income net loss was approximately $[6.1] million, or $[0.17] per share, EPS $[0.17] per share.

Period: fourth quarter ended December 31, 2022
Net income: net loss was approximately $[6.1] million, or $[0.17] per share
EPS: $[0.17] per share
Result: reported results

Exact text from the filing

For the fourth quarter of 2022, net loss was approximately $[6.1] million, or $[0.17] per share compared to a net income of approximately $3.0 million, or $0.11 per share, for the fourth quarter of 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HYPERION DEFI, INC. reported fiscal year ended December 31, 2022 results: net income net loss was approximately $[28.0] million, or $[0.83] per share on approximately 33.6 million weighted average shares o, EPS $[0.83] per share.

Period: fiscal year ended December 31, 2022
Net income: net loss was approximately $[28.0] million, or $[0.83] per share on approximately 33.6 million weighted average shares o
EPS: $[0.83] per share
Result: reported results

Exact text from the filing

For the full-year 2022, net loss was approximately $[28.0] million, or $[0.83] per share on approximately 33.6 million weighted average shares outstanding, and this compares to a net loss of approximately $[12.8] million, or $[0.49] per share, for the full year 2021 on approximately 26.3 million weighted average shares outstanding.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

HYPERION DEFI, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-039153

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.